 Koninklijke Philips NV NYSE: PHG reported a fourth-quarter FY21 sales decline of 5.6 year-on-year to 4.9 billion. The company attributed the comparable sales decline of 10 to headwinds caused by global supply chain challenges, postponement of equipment installations in hospitals, and consequences of the Respironics field action. 